Keros Therapeutics Inc (KROS)
48.72
+0.24
(+0.51%)
USD |
NASDAQ |
May 28, 16:00
48.72
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics Shares Outstanding: 36.08M for May 1, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 01, 2024 | 36.08M |
April 01, 2024 | 36.07M |
March 31, 2024 | 36.07M |
February 21, 2024 | 35.98M |
January 09, 2024 | 35.87M |
December 31, 2023 | 31.84M |
October 31, 2023 | 29.96M |
September 30, 2023 | 29.68M |
July 28, 2023 | 29.66M |
June 30, 2023 | 29.66M |
April 27, 2023 | 29.58M |
April 10, 2023 | 29.55M |
March 31, 2023 | 29.55M |
February 23, 2023 | 28.54M |
December 31, 2022 | 27.54M |
October 27, 2022 | 27.54M |
September 30, 2022 | 26.08M |
July 29, 2022 | 25.76M |
June 30, 2022 | 24.43M |
April 29, 2022 | 24.03M |
April 05, 2022 | 24.02M |
Date | Value |
---|---|
March 31, 2022 | 24.00M |
March 02, 2022 | 24.00M |
December 31, 2021 | 23.97M |
October 28, 2021 | 23.40M |
September 30, 2021 | 23.40M |
July 27, 2021 | 23.34M |
June 30, 2021 | 23.33M |
April 29, 2021 | 23.30M |
April 05, 2021 | 23.28M |
March 31, 2021 | 23.27M |
March 19, 2021 | 23.27M |
December 31, 2020 | 23.19M |
November 17, 2020 | 23.18M |
November 03, 2020 | 20.19M |
September 30, 2020 | 20.19M |
August 07, 2020 | 20.17M |
June 30, 2020 | 20.16M |
May 15, 2020 | 20.15M |
April 13, 2020 | 20.09M |
April 08, 2020 | 19.19M |
April 01, 2020 | 18.19M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
18.19M
Minimum
Apr 01 2020
36.08M
Maximum
May 01 2024
25.97M
Average
24.01M
Median
Shares Outstanding Benchmarks
Morphic Holding Inc | 50.09M |
NovaBay Pharmaceuticals Inc | 37.83M |
Palatin Technologies Inc | 16.14M |
iBio Inc | 8.624M |
Theriva Biologics Inc | 17.28M |